Home › Funds › Aufman Associates Inc › ABBV

Aufman Associates Inc position in ABBV

ABBVIE INC · Health Care

Aufman Associates Inc reported holding 3,066 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$802K, representing 0.33% of its reported portfolio and ranking #22 among its reported holdings. Aufman Associates Inc has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)3.07K sh
Reported value held$802.03K
Portfolio Weight0.33%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Aufman Associates Inc's ABBV position evolved

Aufman Associates Inc first disclosed a stake in ABBV in Q3 2023 at 2,460 shares (US$367K). The position peaked in Q2 2026 at 3,196 shares, worth US$804K. Across 13 filings, Aufman Associates Inc increased the stake 1 time(s), trimmed it 3 time(s) and left it unchanged 8 time(s). The most recent filing (Q3 2026) shows 3,066 shares valued at US$802K — a reduction of -130 shares quarter over quarter.. Notable position changes include a 35% increase in Q3 2024 (shares fell 9% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.46K $366.75K New
Q4 2023 2.46K $381.32K Hold
Q1 2024 2.46K $448.11K Hold
Q2 2024 2.46K $422.10K Hold
Q3 2024 3.33K $657.82K Add
Q4 2024 3.33K $591.96K Hold
Q1 2025 3.26K $683.32K Reduce
Q2 2025 3.26K $605.40K Hold
Q3 2025 3.26K $755.17K Hold
Q4 2025 3.26K $745.23K Hold
Q1 2026 3.26K $709.35K Hold
Q2 2026 3.20K $804.24K Reduce
Q3 2026 3.07K $802.03K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 31 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$30.26B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has Aufman Associates Inc held ABBV?

Aufman Associates Inc has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Aufman Associates Inc's current position in ABBV?

As of Q3 2026, Aufman Associates Inc holds 3.07K shares of ABBV (ABBVIE INC), valued at $802.03K, representing 0.33% of its reported portfolio and ranking #22.

Has Aufman Associates Inc been buying or selling ABBV?

In the latest 13F filing (Q3 2026), Aufman Associates Inc reduced its position in ABBV. The position peaked in Q2 2026 at 3.20K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.